000 | 01564 a2200505 4500 | ||
---|---|---|---|
005 | 20250514024157.0 | ||
264 | 0 | _c20020610 | |
008 | 200206s 0 0 eng d | ||
022 | _a0022-3417 | ||
024 | 7 |
_a10.1002/path.1045 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLynch, J | |
245 | 0 | 0 |
_aMitotic counts provide additional prognostic information in grade II mammary carcinoma. _h[electronic resource] |
260 |
_bThe Journal of pathology _cMar 2002 |
||
300 |
_a275-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aBreast Neoplasms _xmortality |
650 | 0 | 4 |
_aCarcinoma, Ductal, Breast _xmortality |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFlow Cytometry |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKi-67 Antigen _xanalysis |
650 | 0 | 4 | _aLogistic Models |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMitotic Index |
650 | 0 | 4 | _aPilot Projects |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 |
_aReceptors, Estrogen _xanalysis |
650 | 0 | 4 | _aS Phase |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aPattekar, R | |
700 | 1 | _aBarnes, D M | |
700 | 1 | _aHanby, A M | |
700 | 1 | _aCamplejohn, R S | |
700 | 1 | _aRyder, K | |
700 | 1 | _aGillett, C E | |
773 | 0 |
_tThe Journal of pathology _gvol. 196 _gno. 3 _gp. 275-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/path.1045 _zAvailable from publisher's website |
999 |
_c11765530 _d11765530 |